The Tyrosine Phosphatase SHP2 Regulates Focal Adhesion Kinase to Promote EGF-Induced Lamellipodia Persistence and Cell Migration

被引:55
作者
Hartman, Zachary R. [1 ]
Schaller, Michael D. [1 ]
Agazie, Yehenew M. [1 ,2 ]
机构
[1] W Virginia Univ, Dept Biochem, Sch Med, Morgantown, WV 26506 USA
[2] W Virginia Univ, Mary Babb Randolph Canc Ctr, Sch Med, Morgantown, WV 26506 USA
关键词
EPIDERMAL-GROWTH-FACTOR; HELICOBACTER-PYLORI CAGA; NEGATIVE BREAST-CANCER; ACUTE MYELOID-LEUKEMIA; MOLECULAR-MECHANISM; PTPN11; MUTATIONS; NOONAN-SYNDROME; FACTOR RECEPTOR; PROTEIN; ACTIVATION;
D O I
10.1158/1541-7786.MCR-12-0578
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The Src homology phosphotyrosyl phosphatase 2 (SHP2) is a positive effector of receptor tyrosine kinases (RTK) signaling. Furthermore, SHP2 is known to promote cell migration and invasiveness, key steps in cancer metastasis. To date, however, the mechanism by which SHP2 regulates cell movement is not fully understood. In the current report, a new role for SHP2 in regulating cell migration has been suggested. We show that SHP2 mediates lamellipodia persistence and cell polarity to promote directional cell migration in the MDA-MB231 and the MDA-MB468 basal-like and triple-negative breast cancer cell lines. We further show that SHP2 modulates the activity of focal adhesion kinase (FAK) by dephosphorylating pTyr397, the autophosphorylation site that primes FAK function. Because hyperactivation of FAK is known to counter the maturation of nascent focal complexes to focal adhesions, we propose that one of the mechanisms by which SHP2 promotes lamellipodia persistence is by downregulating FAK activity through dephosphorylation of pTyr397. The finding that inhibition of FAK activity partially restores EGF-induced lamellipodia persistence and cell migration in SHP2-silenced cells supports our proposition that SHP2 promotes growth factor-induced cell movement by acting, at least in part, on FAK. However, the effect of SHP2 inhibition in nonstimulated cells seems FAK independent as there was no significant difference between the control and the SHP2-silenced cells in pY397-FAK levels. Also, FAK inhibition did not rescue Golgi orientation defects in SHP2-silenced cells, suggesting that SHP2 acts through other mechanisms to promote cell polarity. (C)2013 AACR.
引用
收藏
页码:651 / 664
页数:14
相关论文
共 46 条
  • [1] Tyrosine phosphatase SHP2 promotes breast cancer progression and maintains tumor-initiating cells via activation of key transcription factors and a positive feedback signaling loop
    Aceto, Nicola
    Sausgruber, Nina
    Brinkhaus, Heike
    Gaidatzis, Dimos
    Martiny-Baron, Georg
    Mazzarol, Giovanni
    Confalonieri, Stefano
    Quarto, Micaela
    Hu, Guang
    Balwierz, Piotr J.
    Pachkov, Mikhail
    Elledge, Stephen J.
    van Nimwegen, Erik
    Stadler, Michael B.
    Bentires-Alj, Mohamed
    [J]. NATURE MEDICINE, 2012, 18 (04) : 529 - 537
  • [2] Molecular mechanism for a role of SHP2 in epidermal growth factor receptor signaling
    Agazie, YM
    Hayman, MJ
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 2003, 23 (21) : 7875 - 7886
  • [3] The phosphotyrosine phosphatase SHP2 is a critical mediator of transformation induced by the oncogenic fibroblast growth factor receptor 3
    Agazie, YM
    Movilla, N
    Ischenko, I
    Hayman, MJ
    [J]. ONCOGENE, 2003, 22 (44) : 6909 - 6918
  • [4] Development of an efficient "substrate-trapping" mutant of Src homology phosphotyrosine phosphatase 2 and identification of the epidermal growth factor receptor, Gab1, and three other proteins as target substrates
    Agazie, YM
    Hayman, MJ
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (16) : 13952 - 13958
  • [5] Angiotensin II induces RhoA activation through SHP2-dependent dephosphorylation of the RhoGAP p190A in vascular smooth muscle cells
    Bregeon, Jeremy
    Loirand, Gervaise
    Pacaud, Pierre
    Rolli-Derkinderen, Malvyne
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2009, 297 (05): : C1062 - C1070
  • [6] Cortactin promotes cell motility by enhancing lamellipodial persistence
    Bryce, NS
    Clark, ES
    Leysath, JL
    Currie, JD
    Webb, DJ
    Weaver, AM
    [J]. CURRENT BIOLOGY, 2005, 15 (14) : 1276 - 1285
  • [7] Modulation of α-catenin Tyr phosphorylation by SHP2 positively effects cell transformation induced by the constitutively active FGFR3
    Burks, J.
    Agazie, Y. M.
    [J]. ONCOGENE, 2006, 25 (54) : 7166 - 7179
  • [8] IDENTIFICATION OF A HUMAN SRC HOMOLOGY 2-CONTAINING PROTEIN-TYROSINE-PHOSPHATASE - A PUTATIVE HOMOLOG OF DROSOPHILA CORKSCREW
    FREEMAN, RM
    PLUTZKY, J
    NEEL, BG
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (23) : 11239 - 11243
  • [9] The Tyrosine Phosphatase Shp2 in Development and Cancer
    Grossmann, Katja S.
    Rosario, Marta
    Birchmeier, Carmen
    Birchmeier, Walter
    [J]. ADVANCES IN CANCER RESEARCH, VOL 106, 2010, 106 : 53 - 89
  • [10] Shp-2 mediates v-Src-induced morphological changes and activation of the anti-apoptotic protein kinase Akt
    Hakak, Y
    Hsu, YS
    Martin, GS
    [J]. ONCOGENE, 2000, 19 (28) : 3164 - 3171